DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,060 | -17.4% | 21,212 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $230,153 | +30.7% | 20,458 | +33.8% | 0.00% | 0.0% |
| Q1 2023 | $176,129 | +1.4% | 15,289 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $173,665 | -9.1% | 14,984 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $191,000 | +87.3% | 15,039 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $102,000 | -29.2% | 14,827 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | -24.2% | 14,910 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $190,000 | -28.8% | 15,959 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $267,000 | -24.6% | 16,437 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $354,000 | +142.5% | 16,828 | +79.2% | 0.00% | 0.0% |
| Q1 2021 | $146,000 | -16.1% | 9,389 | +13.5% | 0.00% | 0.0% |
| Q4 2020 | $174,000 | – | 8,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |